The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. KalVista Pharmaceuticals Inc shares valued at $79,828 were sold by Palleiko Benjamin L on Mar 07 ’25. At $11.97 per share, Palleiko Benjamin L sold 6,669 shares. The insider’s holdings dropped to 287,811 shares worth approximately $3.58 million following the completion of this transaction.
Also, Audhya Paul K. sold 2,394 shares, netting a total of over 23,988 in proceeds. Following the sale of shares at $10.02 each, the insider now holds 102,940 shares.
Before that, Yea Christopher had sold 1,918 shares from its account. In a trade valued at $19,218, the CHIEF DEVELOPMENT OFFICER traded KalVista Pharmaceuticals Inc shares for $10.02 each. Upon closing the transaction, the insider’s holdings decreased to 1,918 shares, worth approximately $1.17 million.
As published in their initiating research note from JMP Securities on January 31, 2025, KalVista Pharmaceuticals Inc [KALV] has been a Mkt outperform and the price target has been revised to $19. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 18, 2024, BofA Securities has initiated its “Buy” rating for KALV. Earlier on June 15, 2020, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for KALV stock.
Analyzing KALV Stock Performance
During the last five days, there has been a surge of approximately 7.24%. Over the course of the year, KalVista Pharmaceuticals Inc shares have jumped approximately 46.99%. Shares of the company reached a 52-week high of $12.90 on 03/12/25 and a 52-week low of $7.30 on 01/13/25. A 50-day SMA is recorded $9.59, while a 200-day SMA reached $11.07.
Support And Resistance Levels for KalVista Pharmaceuticals Inc (KALV)
According to the 24-hour chart, there is a support level at 12.19, which, if violated, would cause prices to drop to 11.94. In the upper region, resistance lies at 12.80. The next price resistance is at 13.16. RSI (Relative Strength Index) is 73.46 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.96, which suggests the price will decrease in the coming days. Percent R is at 15.22%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
